Abbreviations - Therapeutic Strategies in Cancer Biology and Pathology - page 191

EGFR EGF receptor

ELAM endothelial leukocyte adhesion molecule

EMT epithelial mesenchymal transition

EPB41L3 erythrocyte membrane protein band 4.1-like 3

ER oestrogen receptor

ERK extracellular signal-regulated kinase

ERM Ezrin-Radixin-Moesin

ESA epithelial cell-specific antigen

ESCC oesophageal squamous cell carcinoma

EZH zeste homologue protein

FADD Fas-associated death domain

FAP familial adenomatous polyposis

FGFR fibroblast growth factor receptor

FOXO forkhead box transcription factors

Fzd frizzled Wnt receptor

GADD growth arrest and DNA-damage inducible proteins

GAP GTPase-activating protein

GLO1 glyoxalase I

GNAI2 guanine nucleotide binding protein alpha inhibiting activity

polypeptide 2

GPCRs G-protein coupled receptors

GRK2 GPCR kinase

GSK3 glycogen synthase kinase-3β

HAT histone acetyl transferase

HCC hepatocellular carcinoma

HDAC histone deacetylase

HER2 human epidermal growth factor receptor 2

HGF hepatocyte growth factor

Hh hedgehog

HIC hypermethylated in cancer

HIF-1 hypoxia-inducible factor 1

HMG high-mobility group protein

HNPCC hereditary non-polyposis colorectal cancer

HSGAG heparan sulfate glycosaminoglycans

HUVEC human vascular endothelial cells

ICAM intercellular adhesion molecule

IDs inhibitor of DNA binding proteins (bHLH transcription factors)

IGF insulin-like growth factor

IGFR IGF receptor

IKK IκB kinase

ING inhibitor of growth suppressor gene

IP3 inositol 1,3,5-trisphosphate

IP3R IP3 receptor

IPF idiopathic pulmonary fibrosis

JNK c-Jun N-terminal kinase